SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015792
Filing Date
2020-11-05
Accepted
2020-11-05 16:45:38
Documents
78
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20200930.htm   iXBRL 10-Q 1798277
2 EX-10.2 bridgerconsultingagree.htm EX-10.2 71045
3 EX-10.3 leasetermination.htm EX-10.3 28377
4 EX-31.1 ex-311q32020.htm EX-31.1 9401
5 EX-31.2 ex-312q32020.htm EX-31.2 9382
6 EX-32.1 ex-321q32020.htm EX-32.1 7113
12 image_01a.jpg GRAPHIC 8624
13 xfor-20200930_g1.jpg GRAPHIC 70840
  Complete submission text file 0001628280-20-015792.txt   7730054

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20200930.xsd EX-101.SCH 64349
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20200930_cal.xml EX-101.CAL 82316
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20200930_def.xml EX-101.DEF 226996
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20200930_lab.xml EX-101.LAB 678968
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20200930_pre.xml EX-101.PRE 407263
14 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20200930_htm.xml XML 1137462
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 201291220
SIC: 2836 Biological Products, (No Diagnostic Substances)